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Background: It is not clear whether the benefits of pulmonary rehabilitation (PR) apply equally
to patients with Chronic Obstructive Pulmonary Disease (COPD) with different levels of starting
disability. We have therefore investigated the effect of pulmonary rehabilitation stratified by
the MRC dyspnoea scale in patients with COPD.
Methods: This is a retrospective, observational study of data collected from 450 consecutive
patients with COPD attending outpatient PR: 247 male, mean (SD) age 69.5 (8.9) yrs and
FEV1 44.6 (19.7)% predicted. The Incremental Shuttle Walk Test (ISWT) was performed before
and after the seven-week course
Results: 395 patients (88%) completed the programme. The mean (SD) baseline ISWT perfor-
mance was 167 (113)m. The distribution of baseline MRC grades was 2 e 15.4%, 3 e 24.9%, 4
e 27.3% and 5 e 32.4%. The mean (95% CI) improvement in ISWT after PR for each MRC scale
grade was highly significant (p< 0.0005); 2 e 66 (50e83)m, 3 e 63 (50e75)m, 4 e 59 (49e70)m,
and 5 e 54 (43e64)m.
Conclusions: Patients with COPD, of all MRC dyspnoea grades, benefit comparably from pulmo-
nary rehabilitation achieving both statistically and clinically meaningful improvements in exer-
cise performance. MRC grade should therefore not be used to exclude patients from pulmonary
rehabilitation.
ª 2009 Elsevier Ltd. All rights reserved.Introduction
Patients with Chronic Obstructive Pulmonary Disease
(COPD) commonly suffer from exertional breathlessness16 2871471.
l-tr.nhs.uk (R.A. Evans).
9 Elsevier Ltd. All rights reservedand fatigue resulting in reduced exercise tolerance. Over
the last two decades strategies have been developed to
decrease disability. Pulmonary rehabilitation (PR) has been
shown to improve exercise performance and health status
in COPD.1 Current guidelines suggest that ‘pulmonary
rehabilitation should be considered for all patients with
chronic respiratory disease who have persistent symptoms,
limited activity, or are unable to adjust to illness in spite of.
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gested that the MRC dyspnoea scale may be an appropriate
guide for patient selection for PR. The MRC Dyspnoea Scale
is a simple to use, validated, reproducible, self-assessed
tool of breathlessness.3e5 A threshold of disability of MRC
dyspnoea scale grades 3e5 has been recommended for
consideration for referral for rehabilitation.6
Few papers have reported the characteristics of
patients that respond favourably to rehabilitation. One
study showed that patients with a ventilatory limitation
to exercise and normal peripheral muscle strength were
less likely to improve their exercise capacity after reha-
bilitation.7 This study did not investigate how baseline
breathlessness affected the response to rehabilitation.
There is also a suggestion that the more severely disabled
patients (MRC grade 5) may do less well from traditional
pulmonary rehabilitation and may need a longer duration
programme.8 Some studies have recommended lower
intensity training 9 or passive training with neuromuscular
stimulation for very disabled patients.10 Equally there is
a paucity of data describing the response to rehabilita-
tion in patients with mild disability (MRC grade 2). Garrod
et al. showed that in COPD patients with MRC grades 1
and 2 breathlessness improved their exercise perfor-
mance as much as patients with MRC grades 3 and 4, but
the numbers were small.11 Currently patients with MRC
grade 2 breathlessness are not included in the
guidelines.2
Our local pulmonary rehabilitation programme provides
individually prescribed, high intensity short-term endur-
ance training. We investigated, in a pragmatic setting,
how disability influences the outcome of pulmonary
rehabilitation in patients with COPD. Our hypothesis was
that patients across the spectrum of disability would
benefit equally from Pulmonary Rehabilitation. The
specific aim was to answer two questions (1) do patients
with severe disability (MRC grade 5) benefit from standard
pulmonary rehabilitation or are other strategies always
necessary? (2) Do patients with mild disability (MRC grade
2) benefit from pulmonary rehabilitation i.e. should they
be referred for PR?Methods
Participants
We completed a retrospective analysis of the data
collected from consecutive patients with Chronic Obstruc-
tive Pulmonary Disease attending outpatient Pulmonary
Rehabilitation at our institution over a two-year period.
Patients were predominantly referred by respiratory
physicians and had a clinical diagnosis of COPD supported
by spirometry with an FEV1/FVC ratio of <70% and an
FEV1< 80% predicted and an MRC scale of 2e5. Patients had
been stable for the preceding three months. Patients were
excluded from rehabilitation if their limitation to exercise
was primarily locomotor or neurological in origin. For safety
reasons patients with unstable angina, a myocardial
infarction in the preceding three months, or aortic stenosis
were also excluded.Outcomes
All patients attended an assessment prior to commencing
the course. The patients’ demographics were recorded,
height and weight measured and spirometry performed.
The primary outcome measure was the Incremental Shuttle
Walk Test (ISWT) distance.12,13 Patients completed two
ISWTs, the first for familiarisation, with a 30 min rest
between tests. Standardised instructions were given on
how to complete the test. Patients reported their disability
resulting from breathlessness using the five-point Medical
Research Council (MRC) dyspnoea scale.3
Intervention: pulmonary rehabilitation (PR)
The seven-week course combined physical training and self-
management education and complies with international
recommendations.2 It involved two hospital visits a week
for 2 h (1 h of exercise and 1 h of education) and daily home
training. The exercise component was predominantly
endurance training. A daily walk was prescribed at 85% VO2
peak determined from the peak performance on the
ISWT.13 Patients were advised to increase their walking
time by a few seconds each day and record their time in
a daily diary (the speed remained constant). The diary and
the individual’s walking speed were checked at each
supervised session. Peripheral strength exercises were
prescribed three times a week using free weights per-
formed once at hospital and twice at home. The education
sessions were multidisciplinary. A patient had completed
the course after attending 14 sessions.
Statistical analysis
Data was analysed using SPSS v. 14.0. One way analysis of
variance (ANOVA) was used to assess any difference in the
baseline ISWT distance, FEV1, or age per MRC grade. Post
hoc analysis, with Bonferroni’s correction factor for
multiple comparisons, was performed for the between
group (MRC grade) differences for the same variables. Chi
squared (with Cramer’s V measure for strength of associa-
tion) was used to assess the differences in gender distri-
bution between each MRC grade. Chi squared test was used
to assess any differences between the number of dropouts
for any MRC grade. Spearman’s correlation analysis was
used to compare the baseline ISWT performance and the
improvement in ISWT with PR. Two way ANOVA was used to
assess the change in ISWT distance after pulmonary reha-
bilitation per MRC grade and per GOLD stage. Univariate
analysis was used to assess the effect of ISWT, age, FEV1,
age or gender on change in ISWT after rehabilitation.
ANCOVA was applied to test the effect of MRC grade on the
change in ISWT, accounting for the difference in FEV1, age,
and gender between the MRC grades. A p value of <0.05
was taken as the level of statistical significance.
Results
Data from 450 consecutive patients over two years was
collected and entered onto a database; 247 male, mean
(SD) age 69.5 (8.9) yrs, FEV1 1.0 (0.5)L, FEV1 40.0 (17.5)%
1072 R.A. Evans et al.predicted. The mean (SD) baseline ISWT performance was
167 (113)m. The MRC grade was recorded in 92% (nZ 415)
of patients. The baseline demographics and distribution of
the MRC dyspnoea scale grades are shown in Table 1.
Nearly a third of patients described their breathlessness
as MRC grade 5 and 15% of patients recorded MRC grade 2.
One patient described MRC grade 1 dyspnoea and has been
excluded from further analysis. The baseline ISWT distance,
for each MRC grade, is also shown in Table 1. There was no
difference in mean age of the patients between the MRC
grades; range 68.3e70.1 yrs (ANOVA pZ 0.550). There
were more males in MRC grade 2 than in the other grades
(pZ 0.008) (Table 1). The mean (SD) FEV1 (L) significantly
decreased with increasing MRC grade, range 1.21 (0.49)L to
0.89 (0.44)L (ANOVA p< 0.0005), but there was no differ-
ence in FEV1 percent predicted between MRC grades
(ANOVA pZ 0.168). The mean ISWT distance decreased
with increasing MRC dyspnoea grade (ANOVA p< 0.0005)
with no overlap between the 95% confidence intervals
(Fig. 1). Post hoc analysis confirmed that the baseline ISWT
distance was significantly different between each MRC
grade (p< 0.0005).
There was no significant difference in mean (SD) ISWT
distance between the groups when stratified by spirometry
according to the GOLD criteria14 although there was a trend
for a decrease in distance walked with increasing GOLD
stage; GOLD stage 2 (22.8%) e 192 (135)m, stage 3 (40.4%)
165 (108)m and stage 4 (36.8%) 154 (96)m pZ 0.081 by
ANOVA and there were no significant intergroup
differences.
Results of pulmonary rehabilitation
395 patients (88%) completed the seven-week programme.
The patients that dropped out of the programme had
significantly worse lung function; mean (SD) FEV1 0.88
(0.41)L vs 1.05 (0.50)L (pZ 0.025), and significantly lower
baseline ISWT performance; 120 (108)m vs 173 (112)m
pZ 0.001. There was no difference in the percentage of
dropouts in each group: MRC grade 2: 15.6%, MRC grade 3:
11.6%, MRC grade 4: 8.0% and MRC grade 5: 16.4%
(pZ 0.127).
The mean improvement in MRC grade was 0.7 p< 0.0005
with 54% of patients improving by at least one MRC grade.
The mean (95% CI) improvement for the ISWT performance
was 59 (54e65)m (p< 0.0005). Over 58% of patients ach-
ieved at least a 48 m improvement in ISWT distance after
pulmonary rehabilitation (the minimum clinically important
difference (MCID) of the ISWT).15 There was no relationshipTable 1
MRC grade 2 3
No.a (% of total) 64 (15.4%) 103 (24.9%
Gender (% male) 73.0% 51.3%
Age (yrs) 69.0 (8.5) 68.3 (9.6)
FEV1 (L) 1.21 (0.49) 1.14 (0.54
FEV1 % predicted 41.3 (36.8e45.8) 43.5 (39.1
ISWT (m) 282 (254e310) 208 (190e
All units described as mean (SD) unless stated.
a Total nZ 414 e one patient with MRC grade 1 was excluded.between baseline ISWT distance and the absolute change in
ISWT distance with rehabilitation, Spearman’s correlation
coefficient 0.018 (pZ 0.728) i.e. a lower baseline ISWT
did not predict a lesser improvement in ISWT distance after
rehabilitation and vice versa (Fig. 2).
The change in ISWT with pulmonary rehabilitation for
the baseline MRC grade and the percentage of patients that
achieved the MCID of the ISWT in each MRC grade are shown
in Table 2. The mean (95% CI) improvement in ISWT
performance with pulmonary rehabilitation for each MRC
grade was highly statistically significant (p< 0.0005) with
moderate effect size and above the threshold of the
minimum clinical important difference of the ISWT (48 m)
see Table 2. There was no statistically significant difference
in the mean improvement in ISWT across the MRC grades
(Two way ANOVA pZ 0.52). Post hoc analysis confirmed
that there were no differences in the change in ISWT
distance between any of the grades (pZ 1.0). The
percentage change in ISWT distance after PR was signifi-
cantly different between the MRC grades (Two way ANOVA
<0.002) Table 2. When expressed as percentage change
MRC grade 5 improved significantly more than MRC grade 2
(pZ 0.009), but there were no other intergrade differ-
ences. There was no significant difference between the
grades in the percentage of patients achieving the MCID of
48 m ranging from 50 to 65% (pZ 0.131) see Table 2.
Patients with MRC grade 2 breathlessness achieved similar
improvements compared to the other grades and half of the
very disabled patients (MRC grade 5) achieved an
improvement greater than the MCID of the ISWT.
Univariate analysis showed that age (ve pZ 0.021),
gender (female ve pZ 0.044) and FEV1 (ve pZ 0.029)
influenced the change in ISWT with PR. The baseline ISWT
distance had no effect on outcome (pZ 0.370). There were
small but statistically significant differences between FEV1
and gender for the MRC grades, but no difference in age. An
ANCOVA was performed and confirmed that there was no
difference between the change in ISWT with rehabilitation
between the MRC grades whilst allowing for the differences
in age, FEV1 and gender.
There was no significant difference in the improvement
in mean (95% CI) ISWT distance after pulmonary rehabili-
tation when stratifying the patients according to GOLD
stage; stage 2 e 56.3 (42.9e69.8)m, stage 3 e 65.4
(55.1e75.6)m and stage 4 e 57.1 (46.8e67.3)m pZ 0.426
by two way ANOVA.
There were 35/450 patients whose baseline MRC grade
was not documented and were therefore excluded from
further analysis. 33 of these patients completed pulmonary4 5
) 113 (27.3%) 134 (32.4%)
54.9% 48.1%
69.8 (8.6) 70.1 (9.3)
) 1.01 (0.45) 0.89 (0.44)
e47.9) 38.7 (34.5e42.9) 37.7 (34.2e41.3)
225) 151 (133e168) 94 (81e107)
Figure 1 ISWT distance per MRC grade.
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distance for these patients was similar 58 (43e72)m
compared to the patients with complete data sets 59
(54e65)m (pZ 0.913). There were no differences in age
(pZ 0.742), gender (pZ 0.351) or lung function
(pZ 0.612) between the group with missing MRC data and
the complete data group.
Discussion
This retrospective, observational study of a large cohort of
patients with COPD demonstrates that the benefits of
outpatient pulmonary rehabilitation apply equally to
people with mild (MRC2) and severe (MRC5) disability.
Patients with COPD were stratified for disability using the
five-point MRC dyspnoea scale. All patients underwent our
usual seven-week high intensity endurance training pro-
gramme. The mean improvement in ISWT distance was
similar and statistically significant for all MRC grades. The
minimum clinically important difference for the ISWT has
been shown to be 48 m15 and the mean improvement in
ISWT was over this level for all the MRC grades.Figure 2 Relationship between baseline ISWT performance
and the change in ISWT with rehabilitation.This is the first time that patients in MRC grade 5 have
shown similar benefits in exercise performance to patients
in the lower (less disabled) grades. At least 50% of the MRC
grade 5 patients gained clinically significant benefits in
exercise performance and gained the largest percentage
change in the ISWT distance after rehabilitation. The pop-
ulation of COPD patients in the current study were partic-
ularly disabled with a mean baseline ISWT of 167 m and
a third classifying themselves as MRC grade 5.
Previous studies have suggested that patients who clas-
sify their breathlessness as MRC grade 5 to do less well with
Pulmonary Rehabilitation.16One study showed a mean
improvement in ISWT distance of 88 m for grades 3 and 4
compared to only 10 m for MRC grade 5.16 However, the
MRC 5 patients in this study had supervised training at home
and the moderately breathless patients received their
training at hospital. The intensity was set on an individual
basis. A recent detailed prospective study discussed the
effect of PR using a three point composite scale based on
the MRC grade.11 The three groups were; 1Zmild (MRC
grades 1 and 2), 2Zmoderate (MRC grades 3 and 4),
3Z severe (MRC grade 5). Although group three (MRC grade
5) did less well with PR compared to groups two and one,
32.6 (74.8)m improvement in 6 min walk test distance
compared to 68.0 (74.2)m and (54.7 45.0)m respectively
p< 0.002, the numbers (nZ 51) did not allow direct
comparison between the five grades. Our data supports the
data by Carone et al. who showed in a large cohort that
patients with chronic respiratory failure gained similar
benefit from PR than those not in respiratory failure.17
Patients in the current study with severe disease did
equally well with PR whether severe disease was defined by
disability (MRC 5) or lung function (GOLD stage 4).
Our programme is individually prescribed at a high
intensity (85% VO2 peak) from the outset. This appears to
be an efficient use of a short duration programme for all
MRC grades with nearly 60% of patients achieving the MCID
in ISWT. Intensity can be used to describe the physiological
training intensity or the number of training sessions per
week. There are only a few studies directly comparing
physiological training intensities. Overall these support
higher training intensity rather than moderate.18e20
However, there is some evidence that using a smaller
muscle mass may delay ventilatory limitation and allow
some patients to exercise for longer.21 Patients with MRC 5
breathlessness had a lower FEV1 percent predicted than the
other grades and were therefore more likely to have
a ventilatory limitation. However in this study the patients
made similar improvements with high intensity endurance
training irrespective of MRC grade. Complicated training
regimens either require more staff or accommodate less
patients. The training prescription in this study is simple,
easy to apply and effective for the majority of patients.
Only 15% of patients in this cohort described mild
disability (MRC grade 2). This group also made significant
and clinically important improvements in ISWT distance;
mean 66 m (p< 0.0005), 65% achieving more than 48 m.
Patients with MRC grade 2 breathlessness also made
significant improvements in the study by Garrod et al.
Currently the selection criteria for PR are directed at
patients with established disability rather than at pre-




MRC grade 2 3 4 5
Change in ISWTa (m) 66 (50e83) 63 (50e75) 59 (49e70) 54 (43e64)
Effect size 0.61 0.65 0.58 0.62
p <0.0005 <0.0005 <0.0005 <0.0005
% Achieving
the MCID 48 m
65% 58% 63% 50%
% Change in ISWT (m) 26.5 (20.0e33.1)% 37.1 (28.0e46.3)% 68.5 (39.8e97.0) 78.7 (59.8e97.7)
a Mean (95% CI).
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avoid their symptoms by becoming less active leading to de-
conditioning which in turn worsens the symptoms. It may be
possible to interrupt this cycle early in patients with mild
disability (MRC grade 2).
Previous work has shown that the MRC scale 3e5 is
a good descriptor of exercise capacity measured by the
ISWT.22 This study expands this to include MRC grade 2 and
shows that the mean ISWT clearly increases with decreasing
MRC grade (Fig. 1).
The minimum clinically important improvement of the
ISWT is an absolute distance. The percentage change in
ISWT that constitutes an important clinical difference is
unknown. Fig. 2 demonstrates that the improvement in
ISWT distance does not correlate with the baseline ISWT.
Although the improvement in distance is absolute, the
speed at which this is achieved is different i.e. the mean
ISWT distance for MRC 2 was 280 m which at level 8 is
a walking speed of 1.35 m/s in comparison to a mean ISWT
distance of 90 m for MRC 5 which at level 3 is a walking
speed of 0.84 m/s. This is likely to be why the magnitude of
walking distance achieved with PR is not affected by the
starting distance and why an absolute improvement for the
minimum clinical important difference may be relevant
across the spectrum of disability. The conclusions for this
paper are therefore based on the absolute improvement in
ISWT rather than the percentage change.
This data supports the knowledge that the degree of
lung impairment (assessed by spirometry) correlates poorly
with exercise capacity.23 There was no statistical differ-
ence between the baseline ISWT distance for patients when
stratified by the GOLD criteria and there was no difference
between the MRC grades in FEV1 percent predicted.
Patients classified by the GOLD criteria into stages 2e4 all
improved equally and made clinically significant improve-
ments in ISWT distance. Berry et al. examined the effects
of rehabilitation comparing stage 1 to stages 2 and 3
disease stratified by the then current ATS recommenda-
tions.24 All three groups made improvements in 6 min walk
distance and similar improvements in health status
measured by the four domains of the Chronic Respiratory
Questionnaire (CRQ). This and the current study support
the inclusion of patients with mild disease to rehabilitation
programmes whether that’s determined by spirometry
(impairment) or MRC dyspnoea scale (disability).
There are limitations to this study. The study was
retrospective, but this does mean the performance of
patients was not influenced by direct study conditions.
There was some missing data (8%) for the baseline MRC
grade excluding these 35 patients from further analysis.However, there were no significant differences in baseline
demographics, exercise performance or improvement in
ISWT distance with rehabilitation between the group with
missing data and the complete data group. No significant
bias should therefore have been introduced. This series is
much larger than previous reported studies, but only the
effect on exercise performance is reported. The patients in
this study were stable outpatients and the conclusions may
not be extrapolated to other populations.
In summary, patients of all MRC dyspnoea grades benefit
comparably from pulmonary rehabilitation achieving both
statistically and clinically meaningful improvements in
exercise performance. MRC grade should not therefore be
used as a discriminator when selecting patients for
pulmonary rehabilitation.
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